相关实验视频

Updated: Sep 13, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

乙化阅读器YEATS2在肝细胞癌管理中的价值

Yongjie Shi¹, Qiwen Xiao¹, Weichun Xiao²

¹Department of Clinical Laboratory, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.

Scientific reports

|July 30, 2025

概括

含有2 (YEATS2) 的过度表达的叶茨域驱动肝细胞癌 (HCC) 的进展. YEATS2显示出作为预测HCC治疗反应和患者结果的生物标志物的潜力.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

肝细胞癌 (HCC) 是一个重要的全球健康问题.
含有Yeats域2 (YEATS2) 的过度表达经常在HCC中观察到,并与瘤进展有关.
PI3K/AKT通路与HCC的发展有关,并受到 YEATS2.2 的影响.

研究的目的:

为了研究 YEATS2 在肝细胞癌中的致癌功能.
评估YEATS2作为HCC的预后和预测生物标志物.
探索 YEATS2 在瘤进展,免疫微环境调节和治疗反应中的作用.

主要方法:

在体外实验包括细胞增殖和侵入测试.
生物信息学分析以评估YEATS2表达及其与临床结果的相关性.
皮质 - 介质细胞过渡 (EMT) 分析.
瘤免疫微环境评估.

主要成果:

YEATS2的过度表达促进了HCC细胞的增殖,入侵和EMT.
YEATS2与瘤进展和患者预后有显著的相关性.
YEATS2影响瘤的免疫微环境.
YEATS2表达预测了免疫疗法和化疗的反应.

结论:

YEATS2是一种致癌基因,通过包括EMT在内的机制驱动HCC的进展.
YEATS2作为HCC的有价值的预后生物标志物.
YEATS2有可能成为HCC个性化治疗选择的预测生物标志物.
YEATS2的血清稳定性表明它作为HCC管理的非侵入性生物标志物的实用性.

关键词:

肝细胞癌是肝细胞癌.瘤发生的发生因子.治疗策略治疗策略两年的时间.

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

相关概念视频

Phase II Reactions: Acetylation Reactions

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Spreading of Chromatin Modifications

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...